These results not only demonstrated the crucial role of NKX2-8 reduction in osteoclastogenesis-induced breast cancer bone metastasis but also represent a potential therapeutic strategy to treat bone metastasis of NKX2-8-downregulated breast cancer. The gene discussed is NKX2-8; the disease is breast cancer.